Krystal Biotech (KRYS) Inventory (2023 - 2026)

Krystal Biotech (KRYS) has 4 years of Inventory data on file, last reported at $42.6 million in Q1 2026.

• For the quarter ending Q1 2026, Inventory rose 42.43% year-over-year to $42.6 million; the trailing twelve-month figure through Mar 2026 stood at $42.6 million (up 42.43% YoY), and the FY2025 full-year result was $40.5 million, up 52.69% from the prior year.
• Inventory grew to $42.6 million in Q1 2026, from $40.5 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $42.6 million in Q1 2026 to a low of $5.3 million in Q3 2023.
• A 4-year average of $23.8 million and a median of $26.5 million in 2024 frame the typical range for Inventory.
• Across the five-year window, Inventory surged 279.5% in 2024 and surged 42.43% in 2026, its largest moves.
• Tracing KRYS's Inventory over 4 years: stood at $7.0 million in 2023, then surged by 279.5% to $26.5 million in 2024, then jumped by 52.69% to $40.5 million in 2025, then gained by 5.36% to $42.6 million in 2026.
• Business Quant data shows KRYS's Inventory at $42.6 million in Q1 2026, $40.5 million in Q4 2025, and $37.6 million in Q3 2025.